Editas Medicine, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Editas Medicine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Editas Medicine, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2016 | EDIT | Editas Medicine, I ... | bng0, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,888,888 | 0 | 0 | |
| Feb 10 2016 | EDIT | Editas Medicine, I ... | bng0, LLC | 10% Owner | Buy | C | 0.00 | 2,649,572 | 0 | 2,649,572 | 0 to 2.6 M |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 199,999 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,051,060 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,325,708 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 800,001 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 4,204,240 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 5,302,834 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 76,922 | 0 | 991,060 | 914.1 K to 991.1 K (+8.41 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 404,253 | 0 | 914,138 | 509.9 K to 914.1 K (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 509,885 | 0 | 509,885 | 0 to 509.9 K |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 307,692 | 0 | 3,964,256 | 3.7 M to 4 M (+8.41 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,617,015 | 0 | 3,656,564 | 2 M to 3.7 M (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 2,039,549 | 0 | 2,039,549 | 0 to 2 M |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 5,255,300 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 6,628,542 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 85,469 | 0 | 4,656,173 | 4.6 M to 4.7 M (+1.87 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 2,021,269 | 0 | 4,570,704 | 2.5 M to 4.6 M (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 2,549,435 | 0 | 2,549,435 | 0 to 2.5 M |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Nikolic Boris | Director | Option Exercise | C | 0.00 | 6,888,888 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Nikolic Boris | Director | Buy | C | 0.00 | 2,649,572 | 0 | 2,649,572 | 0 to 2.6 M |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | C | 0.00 | 11,111 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | C | 0.00 | 192,027 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Buy | C | 0.00 | 4,273 | 0 | 1,441,095 | 1.4 M to 1.4 M (+0.30 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Buy | C | 0.00 | 73,856 | 0 | 1,436,822 | 1.4 M to 1.4 M (+5.42 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 5,255,300 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 6,628,542 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 85,469 | 0 | 4,656,173 | 4.6 M to 4.7 M (+1.87 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 2,021,269 | 0 | 4,570,704 | 2.5 M to 4.6 M (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 2,549,435 | 0 | 2,549,435 | 0 to 2.5 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 854,700 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 854,700 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Flynn James E | 10% Owner | Buy | P | 16.00 | 100,000 | 1,600,000 | 954,700 | 854.7 K to 954.7 K (+11.70 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 854,700 | 0 | 854,700 | 0 to 854.7 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 854,700 | 0 | 854,700 | 0 to 854.7 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 5,335 | 0 | 266,782 | 261.4 K to 266.8 K (+2.04 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 261,447 | 0 | 261,447 | 0 to 261.4 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 481,567 | 0 | 481,567 | 0 to 481.6 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 15,072 | 0 | 15,072 | 0 to 15.1 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 256,986 | 0 | 256,986 | 0 to 257 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 20,407 | 0 | 2,729,808 | 2.7 M to 2.7 M (+0.75 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 0.00 | 1,000,000 | 0 | 2,709,401 | 1.7 M to 2.7 M (+58.50 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 5,335 | 0 | 266,782 | 261.4 K to 266.8 K (+2.04 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 261,447 | 0 | 261,447 | 0 to 261.4 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 481,567 | 0 | 481,567 | 0 to 481.6 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 15,072 | 0 | 15,072 | 0 to 15.1 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 256,986 | 0 | 256,986 | 0 to 257 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 20,407 | 0 | 2,729,808 | 2.7 M to 2.7 M (+0.75 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 1,000,000 | 0 | 2,709,401 | 1.7 M to 2.7 M (+58.50 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,255,300 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,628,542 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 4,656,176 | 0 | 4,656,176 | 0 to 4.7 M |
| Feb 04 2016 | EDIT | Editas Medicine, I ... | MENDLEIN JOHN | Director | Option Exercise | A | 16.00 | 96,153 | 1,538,448 | 96,153 | |
| Feb 04 2016 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Option Exercise | A | 16.00 | 38,461 | 615,376 | 38,461 |